Codexis Inc (CDXS)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Codexis Inc (CDXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012219
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Codexis Inc (Codexis) is a biotechnology company, which focuses on the development of biocatalysts for commercial scale production of fine chemicals and pharmaceuticals. The company’s product portfolio includes pharmaceutical enzymes and intermediates, active pharmaceutical ingredients (APIs), Codex screening panels and kits, and enzyme platforms. It also offers a wide range of biocatalysis solutions ranging from screening and optimization to commercial supply of biocatalysts. Codexis discovers, identifies, optimizes and produces enzymes by using its technology platforms such as CodeEvolver, protein engineering technology platform, which introduces mutation into genes to transform the enzymes that they produce. The company serves specialist businesses, pharmaceutical, food manufacturing and chemical companies. Codexis is headquartered in Redwood City, California, the US.

Codexis Inc (CDXS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Codexis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Codexis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Codexis Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Codexis Enters into Agreement with Nestle Health Science 11
Codexis Enters into R&D Agreement with Biopharmaceutical Company 13
Purolite Enters Into Co-Development Agreement With Codexis For Immobilized Enzymes 14
Strem Chemicals Enters Into Distribution Agreement With Codexis For Codex Screening Kits 15
Albany Molecular Research Enters Into Smartsourcing Partnership With Codexis 16
Licensing Agreements 17
Merck Enters into Licensing Agreement with Codexis for CodeEvolver Platform Technology 17
Codexis Enters into Licensing Agreement with GlaxoSmithKline for CodeEvolver Protein Engineering Platform 19
Merck Extends Licensing Agreement with Codexis 21
Equity Offering 22
Codexis Raises USD25.3 Million in Public Offering of Shares 22
Asset Transactions 24
Intrexon Acquires Laboratory Operations From Codexis US$1.5 Million 24
Acquisition 25
Raizen Energia Acquires 15.7% Stake In Codexis From Equilon Enterprises 25
Codexis Inc – Key Competitors 26
Codexis Inc – Key Employees 27
Codexis Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Financial Announcements 29
Nov 09, 2017: Codexis Reports Financial Results for the Third Quarter of 2017 29
Aug 09, 2017: Codexis Reports Financial Results for the Second Quarter of 2017 31
May 09, 2017: Codexis Reports Financial Results for the First Quarter of 2017 33
Mar 09, 2017: Codexis Reports 2016 Fourth Quarter and Full Year Financial Results 34
Nov 08, 2016: Codexis Reports Financial Results for the Third Quarter of 2016 36
Aug 09, 2016: Codexis Reports Financial Results for the Second Quarter of 2016 38
May 09, 2016: Codexis Reports Financial Results for the First Quarter of 2016 40
Mar 03, 2016: Codexis Reports 2015 Fourth Quarter and Full Year Financial Results 41
Corporate Communications 43
Dec 01, 2016: Codexis names new chairman 43
Mar 03, 2016: Codexis Adds Life Sciences Industry Veteran David V. Smith to Its Board of Directors 44
Legal and Regulatory 45
Aug 08, 2017: Codexis Obtains Court Order Awarding Summary Judgment of Patent Infringement against EnzymeWorks 45
Feb 22, 2016: Codexis Files Lawsuit against EnzymeWorks and CEO Junhua “Alex” Tao for Patent Infringement and Misappropriation of Trade Secrets 46
Government and Public Interest 47
Jul 19, 2016: Adding Value in Pharma: Applying Advanced Protein Engineering Technologies to Biotherapeutic Development 47
Product News 49
Jan 06, 2017: Codexis to Offer High-Performance Enzymes for Diagnostics Markets 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Codexis Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Codexis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Codexis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Codexis Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Codexis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Codexis Enters into Agreement with Nestle Health Science 11
Codexis Enters into R&D Agreement with Biopharmaceutical Company 13
Purolite Enters Into Co-Development Agreement With Codexis For Immobilized Enzymes 14
Strem Chemicals Enters Into Distribution Agreement With Codexis For Codex Screening Kits 15
Albany Molecular Research Enters Into Smartsourcing Partnership With Codexis 16
Merck Enters into Licensing Agreement with Codexis for CodeEvolver Platform Technology 17
Codexis Enters into Licensing Agreement with GlaxoSmithKline for CodeEvolver Protein Engineering Platform 19
Merck Extends Licensing Agreement with Codexis 21
Codexis Raises USD25.3 Million in Public Offering of Shares 22
Intrexon Acquires Laboratory Operations From Codexis US$1.5 Million 24
Raizen Energia Acquires 15.7% Stake In Codexis From Equilon Enterprises 25
Codexis Inc, Key Competitors 26
Codexis Inc, Key Employees 27
Codexis Inc, Subsidiaries 28

★海外企業調査レポート[Codexis Inc (CDXS)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Murphy Oil Corporation:企業の戦略・SWOT・財務分析
    Murphy Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Murphy Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • CNOOC Limited:企業の戦略・SWOT・財務分析
    CNOOC Limited - Strategy, SWOT and Corporate Finance Report Summary CNOOC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • International SOS Pte Ltd:企業の戦略的SWOT分析
    International SOS Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Boulevard Holdings, Inc.:企業の戦略・SWOT・財務分析
    Boulevard Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Boulevard Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Gulfslope Energy Inc (GSPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Gulfslope Energy Inc (Gulfslope Energy), formerly Plan A Promotions Inc, is an oil and gas company. The company’s business activities include acquisition, exploration, development, and production of crude oil and natural gas. It utilizes 3D seismic data to identify high quality exploration p …
  • M. A. Mortenson Co:戦略・SWOT・企業財務分析
    M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report Summary M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Mauna Kea Technologies SAS (MKEA):医療機器:M&Aディール及び事業提携情報
    Summary Mauna Kea Technologies SAS (MKT) is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides confocal laser endomicroscopy platform. MKT’s cellvizio is an endomicro …
  • Eagle Insurance Ltd:企業の戦略・SWOT・財務分析
    Eagle Insurance Ltd - Strategy, SWOT and Corporate Finance Report Summary Eagle Insurance Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • The Tata Power Company Limited:企業の戦略・SWOT・財務情報
    The Tata Power Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Tata Power Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Jo-Ann Stores, Inc.:企業の戦略・SWOT・財務情報
    Jo-Ann Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jo-Ann Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Safe Orthopaedics SA (SAFOR):企業の財務・戦略的SWOT分析
    Summary Safe Orthopaedics SA (Safe Orthopaedics) is medical device company that manufactures and markets devices for spinal surgery. The company’s products comprise implants and surgical instruments. It also offers modular cervical cages, percutaneous auto-correction screws, modular anchorage screws …
  • Strand Life Sciences Pvt Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Strand Life Sciences Pvt Ltd (Strand Life) is a healthcare technology company that develops offers bioinformatics and clinical diagnostic software products. The company offers bioinformatics software for most analytics platforms such as microarrays, mass spectrometry, next generation sequenc …
  • Adapt Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Adapt Pharma Ltd (Adapt Pharma) is a drug discovery and development company that manufactures and distributes prescription medicines. The company’s product Narcan (naloxone hydrochloride) nasal spray is an opioid antagonist that is indicated for the emergency treatment of opioid overdose as …
  • Coal India Ltd:企業のM&A・事業提携・投資動向
    Coal India Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coal India Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • BioView Ltd (BIOV):企業の財務・戦略的SWOT分析
    BioView Ltd (BIOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • AptarGroup Inc:企業の戦略・SWOT・財務情報
    AptarGroup Inc - Strategy, SWOT and Corporate Finance Report Summary AptarGroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Kawasaki Heavy Industries Ltd (7012):企業の財務・戦略的SWOT分析
    Kawasaki Heavy Industries Ltd (7012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Mitteldeutsche Braunkohlengesellschaft mbH:企業の戦略的SWOT分析
    Mitteldeutsche Braunkohlengesellschaft mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • DFDS AS (DFDS):企業の財務・戦略的SWOT分析
    DFDS AS (DFDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Cullinan Holdings Limited:企業の戦略・SWOT・財務分析
    Cullinan Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Cullinan Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆